热门资讯> 正文
BioTE报告第二季度GAAP每股收益为-0.19美元
2024-08-09 20:22
- Biotech Acquisition Co Ordinary Shares - Class A(BIOT) 0
- Biote Corp. - Class A Common Stock(BTMD) 0
- iShares LifePath Target Date 2025 ETF USD(ITDA) 0
- BIOTE press release (NASDAQ:BTMD): Q2 GAAP EPS of -$0.19.
- Revenue of $49.2 million.
- Procedure revenue of $38.4 million.
- Gross profit margin of 68.9%, including a $1.2 million inventory step-up related to the acquisition of Asteria Health.
- Adjusted EBITDA for the second quarter of 2024 was $12.7 million, with an Adjusted EBITDA margin of 25.9%.
More on BIOTE
- Seeking Alpha’s Quant Rating on BIOTE
- Historical earnings data for BIOTE
- Financial information for BIOTE
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
